Israel - hebraico - Ministry of Health

ferring pharmaceuticals ltd - atosiban - solution for injection - atosiban 7.5 mg/ml - atosiban - atosiban - atosiban is indicated to delay imminent pre-term birth in pregnant women with: - regular uterine contractions of at least 30 seconds duration at a rate of 4 or more per 30 minutes - a cervical dilation of 1 to 3 cm (0-3 for iparas) and effacement of 50 % or more - age: 18 years and above - a gestational age from 24 until 33 completed weeks - a normal foetal heart rate.

Israel - hebraico - Ministry of Health

ferring pharmaceuticals ltd - atosiban - atosiban 7.5 mg/ml - atosiban

Israel - hebraico - Ministry of Health

propharm ltd - atosiban - atosiban 7.5 mg / 1 ml - atosiban

Israel - hebraico - Ministry of Health

pharmalogic ltd - atosiban as acetate - תרכיז להכנת תמיסה לאינפוזיה - atosiban as acetate 7.5 mg/ml - atosiban

Israel - hebraico - Ministry of Health

pharmalogic ltd - atosiban as acetate - תמיסה להזרקה - atosiban as acetate 7.5 mg/ml - atosiban

Israel - hebraico - Ministry of Health

pharmalogic ltd - atosiban as acetate - תרכיז להכנת תמיסה לאינפוזיה - atosiban as acetate 7.5 mg/ml - atosiban

Israel - hebraico - Ministry of Health

a.l. medi-market ltd. - atosiban as acetate - atosiban as acetate 7.5 mg/ml - atosiban